Work

Varenicline Is a Potent Partial Agonist at α6β2* Nicotinic Acetylcholine Receptors in Rat and Monkey Striatum

Year: 2012

Type: article

Source: Journal of Pharmacology and Experimental Therapeutics

DOI: 10.1124/jpet.112.194852

Authors: Tanuja Bordia, Maya Hrachova, Matthew Chin, J. Michael McIntosh, Maryka Quik

Institution: SRI International

Language: English

Topic: Nicotinic Acetylcholine Receptors Study

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Tobacco-Related Disease Research Program, National Institutes of Health, National Institute on Drug Abuse, National Institute of Neurological Disorders and Stroke

Awards: Studies with Nicotinic Null Mutant Mice, Nicotinic receptors as molecular targets to reduce L-dopa-induced dyskinesias in, G4716797644, Mechanisms of nicotine-mediated decrease in L-dopa induced-dyskinesias

OpenAlex ID: W2070026700

FWCI: 2.783

Cites: 61

Cited by: 71

Related to: 10